RIPK4 and neoplasm: Importantly, expression of Elovl4 drastically reduced tumor burden as well as tumor multiplicity while increasing latency of SCC formation in Ripk4-deficient, Pik3caH1047R-mutant skin (Figure 4E and Supplemental Figure S2C).